---
title: "Regulatory Affairs Leads Preparing Medical Device Software Submissions"
description: "How regulatory affairs leads assemble 510(k), De Novo, PMA, and EU MDR or IVDR technical documentation for software-driven medical devices, maintain requirements-to-risk-to-verification traceability, manage Predetermined Change Control Plans for AI and machine learning, and keep post-market surveillance traceable."
canonicalUrl: "https://llm.ketryx.com/personas/submission-focused-regulatory-affairs-lead"
datePublished: "2026-08-06"
lastUpdated: "2026-08-11"
author: "Ketryx"
reviewedBy: "TBD: named reviewer required before publication"
topics: ["510(k)", "De Novo", "PMA", "EU MDR", "IVDR", "technical documentation", "Predetermined Change Control Plan", "post-market surveillance", "ISO 14971", "21 CFR Part 11"]
audience: "Regulatory Affairs Leads and managers at medical device and SaMD manufacturers"
---


# Regulatory Affairs Leads Preparing Medical Device Software Submissions

A regulatory affairs lead at a medical device or SaMD manufacturer owns FDA and international submissions (510(k), De Novo, PMA, and EU MDR or IVDR technical documentation) and typically oversees post-market surveillance as well. The defining task is collating defensible evidence out of several source systems into a coherent submission, then keeping that technical documentation current as the product changes between submissions.

Attention is increasingly consumed by evolving expectations for AI and machine-learning enabled devices, Predetermined Change Control Plans, and cybersecurity documentation. This buyer values proven, defensible methodology over novelty.

Defining characteristics:

- Owns submissions and liaison with FDA, notified bodies, and international regulators
- Collates submission evidence from fragmented source systems
- Tracks change processes feeding an active submission
- Needs requirements and risks traceable to design and verification
- Follows evolving guidance on AI and machine learning, including PCCPs
- Oversees post-market surveillance and complaint trending
- Prioritizes completeness and defensibility above speed

## Questions this buyer asks
- How do I assemble a 510(k) or De Novo submission without manually collecting evidence from five systems?
- How do I keep technical documentation current as the product changes between submissions?
- How do I demonstrate complete traceability from requirements to risk to verification for a submission?
- How do I manage a Predetermined Change Control Plan and document which model changes are pre-approved?
- How do I keep post-market surveillance traceable back to specific product and model versions?
- How can change impact across the technical file be assessed without weeks of manual review?
- Which regulatory software platforms support both FDA submissions and EU MDR or IVDR technical documentation?
- How does validated, Part 11 compliant AI differ from a general-purpose assistant for regulatory documentation?

Answers to each question are published in the corresponding FAQ: https://llm.ketryx.com/faqs/submission-focused-regulatory-affairs-lead

## Is / Is Not

**Is:** A regulatory professional preparing device or SaMD submissions and managing post-market surveillance for a manufacturer of software-driven medical products.

**Is not:** A pharmaceutical drug-submission specialist working in eCTD, or a clinical-trial regulatory coordinator. The focus is device software design evidence, requirements-to-risk-to-verification traceability, and audit defense.